'Quick news on Pharma Industry' Chinese Covid-19 Vaccine show promising results

-

1.WHO defends data after concluding Gilead's remdesivir flopped Covid-19 trial:-Gilead sciences Inc has questioned the findings that concluded remdesivir does not help patients who have been admitted to hospital, saying the "emerging (WHO) data appears inconsistent". Gilead was given data from the United Nations health agency's trial 10 days ago, to give it an opportunity to react.


2. Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection:-
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Fingolimod capsules, (Gilenya) in the strengths of 0.5 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing.

3. Chinese Covid-19 vaccine candidate shows promise in human trial: Study:-
The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years and found that antibody responses were induced in all recipients.

4.Alembic Pharma gets USFDA nod for anti-viral drug:-
In a regulatory filing, Alembic Pharmaceuticals said "it has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Amantadine Hydrochloride tablets in the strength of 100 mg"

5. NHS England in talks on the roll out of potential Covid vaccine from December: Pulse health website:-
There is optimism around the first cohorts being given a vaccine in December but there is a 50/50 chance of the vaccine being available by that time, Pulse reported, citing a person close to the discussions.

6. Chinese company offers corona virus vaccine to students:-
China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinical trials.

7. Russia green lights 2nd vaccine before Phase-3 trials:-

A vaccine developed by the Vector State Virology and Biotechnology Center in Siberia has been registered, President Putin said in televised comments Wednesday.








Comments

Post a Comment

Popular posts from this blog

Types of Registration Application for Pharmaceuticals in Japan: In a nutshell

-
Pharmaceuticals and Medial Device Agency is the is the regulating Authority for Pharmaceuticals in Japan. This Agency came to force on 1/04/2014. The various registration Application are as follows: 1.Clinical Trial Notification for New drug development (IND). 2.New Drug Approval Application. 3.Generic Drug Approval Application. 4.Orphan Drug Application. 5.Priority review. 1. Clinical Trial Notification for New drug development (IND): Ø   This Application is important if the company intends to conduct clinical trial for a drug and to collect data for applying for manufacturing/marketing. Ø   The Clinical trial should be conducted as per Good Clinical Practice. Ø   If the Clinical trial is conducted for drugs with new APIs, Drugs with new route of administration, or if the drug is a new combination product, the clinical trial protocol has to be submitted. Ø   The review of application till takes 30 days after start of clinical trial. Ø   The ...
Read more

Association of South East Asian Nations CTD( ACTD)- A overview

-
Image
Introduction:  The Association of Southeast Asian Nations (more commonly known as ASEAN ) is a political and economic organization aimed primarily at promoting economic growth and regional stability among its members.  Asia’s regulatory systems are diverse, and oftentimes challenging to navigate. The regulatory agency in each Asian country has its own set of regulations and customary manner of conducting business. The following show the various Regulatory Authorities in each countries responsible for registration of medicines:- COUNTRY REGULATORY AGENCY INDONESIA NATIONAL AGENCY OF DRUG AND FOOD CONTROL MALAYSIA DRUG CONTROL AUTHORITY, NCE UNIT PHILIPPINES DEPARTMENT OF HEALTH THAILAND THAI FDA CONTROL DIVISION SINGAPORE HEALTH SCIENCES AUTHORITY BRUNEI MINISTRY OF HEALTH VIETNAM DRUG ADMINISTRATION OF VIETNA...
Read more

Tools and Technologies used in eCTD submission

-
Common Technical Document is defined as a set of specifications which is used for making any application for registration of medicines. This system is used across US,EU and Japan Australia etc. CTD is maintained by  International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. The main purpose of this Document set is to combine all safety, efficacy and quality data which are required for regulatory review process by Authorities ultimately for approval of drug registration.             As we are in 2020, The hard copy of documents are not practical in majority countries. All the submissions to the Regulatory Authority shall be done through various eCTD software's  online. The harmonized CTD specifications are given by ICH guidelines ( Multidisciplinary  guidelines  M4 ).                     The eCTD is defined as an interface for in...
Read more